PDF
Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
Organization: Public Health Agency of Canada (PHAC)Published: 2023
NACI continues to monitor the rapidly evolving scientific data recognizing that the trajectory of the COVID-19 pandemic remains unclear. Updated recommendations will be made as needed.
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Specific Populations
High Risk Adults
High Risk Children
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Specific Populations,High Risk Adults,High Risk Children Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Specific Populations
High Risk Adults
High Risk Children
Region:
National
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.